Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low dise ...

The role of artificial intelligence, DataDerm, and telehealth in advancing dermatology care was discussed throughout the ...

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 ...

The FDA released results from its investigation of benzene in acne products containing benzoyl peroxide. In light of these ...

Experts discussed advancements in dermatology treatment while emphasizing the value of in-person collaboration and professional rejuvenation at the American Academy of Dermatology 2025 conference.

Outgoing American Academy of Dermatology President Seemal R. Desai, MD, FAAD, passed the torch to Susan C. Taylor, MD, FAAD, ...

Dr Adam Friedman recounts how AAD 2025 highlighted advancements in chronic spontaneous urticaria management, with discussion on new therapies and the role of diet.

Positive results were reported for Johnson & Johnson's psoriasis drug during.a late-breaking research session today at the ...

The latest news from AAD 2025 focused on psoriasis including abstracts, features, and helpful conference information.

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83 rd American Academy of ...

The reduction in itch was the greatest contributor to quality-of-life improvement for adolescents and adults with atopic ...

Kenvue (KVUE) will share new clinical data demonstrating how its brands are leveraging the latest science to shape the future of the Skin ...